News
-
-
COMMUNIQUÉ DE PRESSE
InTiCa Systems SE: Strategic expansion of the product portfolio and repositioning of the segments
InTiCa Systems SE announces strategic expansion of product portfolio and repositioning of segments in Annual Report 2023, focusing on Mobility and Industry & Infrastructure segments for future growth -
COMMUNIQUÉ DE PRESSE
Jaguar Health to Report Phase 3 OnTarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on July 23rd and Hold Investor Webcast that Morning
Jaguar Health announces webcast for cancer supportive care updates including OnTarget trial results. Make Cancer Less Shitty program expands with MCLS Ambassadors -
-
-
COMMUNIQUÉ DE PRESSE
U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract
Applied DNA Sciences announces $1.04 million contract with U.S. Defense Logistics Agency for counterfeit mitigation and product verification programs specific to FSC 5962 microcircuits. Continues support since 2014 -
-
-
-